Abstract:Alzheimer's disease (AD) has become a global threat to the elderly health with a short survival time after diagnosis. Due to the asymptomatic stage during the early development, patients are usually diagnosed at the middle or late stage. Therefore, an efficient tool for AD early diagnosis deserves considerable attention, which could make a significant contribution to the treatment intervention. A fluorescent probe has been widely applied for detecting and visualizing species of interest in vitro and in vivo, and the proper reaction between the probe and analytes is responsible for the fluorescence change to provide a lighting-on or ratiometric responsive pattern with satisfactory sensing behavior. In this work, we report the first attempt to build up an AND-logic probe P2 for AD accuracy diagnosis taking butyrylcholinesterase (BChE) and reactive oxygen species (ROSs) as dual targets. Upon the co-stimulation by these two factors through enzymatic hydrolysis and redox reaction, the NIR emission could be readily turned on. This AND sensing pattern avoided the false-positive response effectively, and other diseases sharing one biomarker could hardly induce a NIR fluorescence response. The sensing assay has also been confirmed to be feasible in vitro and in vivo with good sensibility and selectivity. It is worth mentioning that the probe structure has been optimized in terms of the linkage length. This study shows that probe P2 with a connecting arm of medium length (one methylene, n = 1) has superior sensing performance, promising to provide a reference for the relative structure design.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02943.Experimental section, 1H, 13C NMR, and HR-MS spectral copies of synthesized compounds (Figures S1–S13), fluorescence, and HR-MS spectral profiles (Figures S14–S25), cell cytotoxicity of P1–P3 (Figure S26), spectra of P4 toward ROSs (Figure S27), and living cell imaging of probe P4 (Figure S28) and in vivo imaging (Figure S29) (PDF)This article has not yet been cited by other publications.

AND-Logic Strategy for Accurate Analysis of Alzheimer's Disease Via Fluorescent Probe Lighted Up by Two Specific Biomarkers.

AND-Logic Strategy for Accurate Analysis of Alzheimer’s Disease via Fluorescent Probe Lighted Up by Two Specific Biomarkers

Diagnosis of Alzheimer's Disease and in Situ Biological Imaging Via an Activatable Near-Infrared Fluorescence Probe.

Iterative Design of Near-Infrared Fluorescent Probes for Early Diagnosis of Alzheimer's Disease by Targeting Aβ Oligomers

Current strategies for the development of fluorescence-based molecular probes for visualizing the enzymes and proteins associated with Alzheimer’s disease

Developing a Two-Photon "AND" Logic Probe and Its Application in Alzheimer's Disease Differentiation

An Activatable Near-Infrared Fluorescent Probe with Large Stokes Shift for Visualizing Peroxynitrite in Alzheimer’s Disease Models

A High-Quality CdSe/CdS/ZnS Quantum-Dot-Based FRET Aptasensor for the Simultaneous Detection of Two Different Alzheimer's Disease Core Biomarkers

Development of Near-Infrared Fluorescent Probes for Use in Alzheimers Disease Diagnosis

Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer’s Disease

An activatable near-infrared fluorescent probe with large Stokes shift for visualizing peroxynitrite in Alzheimer's disease models

Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis

Shedding Light on Alzheimer's Disease: Recent Advances in Highly Selective Fluorescent Probes

Application of Biomarker-Derived Fluorescent Probes for the Detection of Alzheimer's Disease

An Activity-Based Sensing Fluorescent Probe for Monitoring Endogenous Peroxynitrite in Alzheimer's Disease Models

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

Design and synthesis of hemicyanine-based NIRF probe for detecting Aβ aggregates in Alzheimer's disease

Light-controlled Fluorescent Probes for Precisely Monitoring Brain Amyloid-Β Aggregates in Alzheimer's Disease

Simultaneous Detection of Alzheimer's Biomarkers using a Visual Electrochemiluminescence Bipolar Array

Environment-Sensitive Near-Infrared Probe for Fluorescent Discrimination of Aβ and Tau Fibrils in AD Brain.

Oxalate-curcumin-based probe for micro- and macroimaging of reactive oxygen species in Alzheimer's disease